Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Anighoro

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Computer-Aided Molecular Design|September 23, 2016
Predicting bioactive conformations and binding modes of macrocyclesAndrew Anighoro, Antonio de la Vega de León, Jürgen Bajorath
Cell Cycle (Georgetown, Tex.)|June 10, 2014
Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2Giulio Rastelli, Andrew Anighoro, Martina Chripkova, et al.
European Journal of Medicinal Chemistry|November 17, 2012
Application of a post-docking procedure based on MM-PBSA and MM-GBSA on single and multiple protein conformationsMiriam Sgobba, Fabiana Caporuscio, Andrew Anighoro, et al.
Journal of Cheminformatics|August 15, 2021
Learning protein-ligand binding affinity with atomic environment vectorsRocco Meli, Andrew Anighoro, Mike J Bodkin, et al.
Journal of Chemical Information and Modeling|February 17, 2015
Computational polypharmacology analysis of the heat shock protein 90 interactomeAndrew Anighoro, Dagmar Stumpfe, Kathrin Heikamp, et al.
Microbiologyopen|December 18, 2014
Role of bifidobacteria in the hydrolysis of chlorogenic acidStefano Raimondi, Andrew Anighoro, Andrea Quartieri, et al.
Bioorganic & Medicinal Chemistry|May 28, 2015
Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinityAndrew Anighoro, Davide Graziani, Ilaria Bettinelli, et al.
Elife|January 17, 2022
A human-based multi-gene signature enables quantitative drug repurposing for metabolic diseaseJames A Timmons, Andrew Anighoro, Robert J Brogan, et al.
Blood Cancer Journal|April 15, 2022
Validation of a small molecule inhibitor of PDE6D-RAS interaction with favorable anti-leukemic effectsSara Canovas Nunes, Serena De Vita, Andrew Anighoro, et al.
Cell Reports Methods|October 5, 2023
RECOVER identifies synergistic drug combinations in vitro through sequential model optimizationPaul Bertin, Jarrid Rector-Brooks, Deepak Sharma, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Computer-Aided Molecular Design|September 23, 2016
Predicting bioactive conformations and binding modes of macrocyclesAndrew Anighoro, Antonio de la Vega de León, Jürgen Bajorath
Cell Cycle (Georgetown, Tex.)|June 10, 2014
Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2Giulio Rastelli, Andrew Anighoro, Martina Chripkova, et al.
European Journal of Medicinal Chemistry|November 17, 2012
Application of a post-docking procedure based on MM-PBSA and MM-GBSA on single and multiple protein conformationsMiriam Sgobba, Fabiana Caporuscio, Andrew Anighoro, et al.
Journal of Cheminformatics|August 15, 2021
Learning protein-ligand binding affinity with atomic environment vectorsRocco Meli, Andrew Anighoro, Mike J Bodkin, et al.
Journal of Chemical Information and Modeling|February 17, 2015
Computational polypharmacology analysis of the heat shock protein 90 interactomeAndrew Anighoro, Dagmar Stumpfe, Kathrin Heikamp, et al.
Microbiologyopen|December 18, 2014
Role of bifidobacteria in the hydrolysis of chlorogenic acidStefano Raimondi, Andrew Anighoro, Andrea Quartieri, et al.
Bioorganic & Medicinal Chemistry|May 28, 2015
Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinityAndrew Anighoro, Davide Graziani, Ilaria Bettinelli, et al.
Elife|January 17, 2022
A human-based multi-gene signature enables quantitative drug repurposing for metabolic diseaseJames A Timmons, Andrew Anighoro, Robert J Brogan, et al.
Blood Cancer Journal|April 15, 2022
Validation of a small molecule inhibitor of PDE6D-RAS interaction with favorable anti-leukemic effectsSara Canovas Nunes, Serena De Vita, Andrew Anighoro, et al.
Cell Reports Methods|October 5, 2023
RECOVER identifies synergistic drug combinations in vitro through sequential model optimizationPaul Bertin, Jarrid Rector-Brooks, Deepak Sharma, et al.
Pageof 2